| Preview | Issue Date | Title | Author(s) |
| 2003 | Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation | Pitson, S.; Moretti, P.; Zebol, J.; Lynn, H.; Xia, P.; Vadas, M.; Wattenberg, B. |
| 2005 | Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells | Wang, L.; Xing, X.; Holmes, A.; Wadham, C.; Gamble, J.; Vadas, M.; Xia, P. |
| 2000 | An oncogenic role of sphingosine kinase | Xia, P.; Gamble, J.; Wang, L.; Pitson, S.; Moretti, P.; Wattenberg, B.; D'Andrea, R.; Vadas, M. |
| 2009 | Chronic increases in sphingosine kinase-1 activity induce a pro-inflammatory, pro-angiogenic phenotype in endothelial cells | Limaye, V.; Xia, P.; Hahn, C.; Smith, M.; Vadas, M.; Pitson, S.; Gamble, J. |
| 2006 | Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1 | Sukocheva, O.; Wadham, C.; Holmes, A.; Albanese, N.; Verrier, E.; Feng, F.; Bernal, A.; Derian, C.; Ullrich, A.; Vadas, M.; Xia, P. |
| 2000 | Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation | Pitson, S.; Moretti, P.; Zebol, J.; Xia, P.; Gamble, J.; Vadas, M.; D'Andrea, R.; Wattenberg, B. |
| 2007 | High glucose attenuates protein S-nitrosylation in endothelial cells - Role of oxidative stress | Wadham, C.; Parker, A.; Wang, L.; Xia, P. |
| 2004 | High-density lipoproteins neutralize C-reactive protein proinflammatory activity | Wadham, C.; Albanese, N.; Roberts, J.; Wang, L.; Bagley, C.; Gamble, J.; Rye, K.; Barter, P.; Vadas, M.; Xia, P. |
| 2000 | Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes | Pitson, S.; D'Andrea, R.; Vandeleur, L.; Moretti, P.; Xia, P.; Gamble, J.; Vadas, M.; Wattenberg, B. |
| 2006 | Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects | Gamble, J.; Xia, P.; Hahn, C.; Drew, J.; Drogemuller, C.; Brown, D.; Vadas, M. |
| 2004 | PPARg agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: Role of diacylglycerol kinase | Verrier, E.; Wang, L.; Wadham, C.; Albanese, N.; Hahn, C.; Gamble, J.; Chatterjee, V.; Vadas, M.; Xia, P. |
| 2009 | Restoring endocrine response in breast cancer cells by inhibition of the sphingosine kinase-1 signaling pathway | Sukocheva, O.; Wang, L.; Verrier, E.; Vadas, M.; Xia, P. |
| 2002 | Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-a signaling | Xia, P.; Wang, L.; Moretti, P.; Albanese, N.; Chai, F.; Pitson, S.; D'Andrea, R.; Gamble, J.; Vadas, M. |
| 2003 | Sphingosine kinase transmits estrogen signaling in human breast cancer cells | Sukocheva, O.; Wang, L.; Albanese, N.; Pitson, S.; Vadas, M.; Xia, P. |
| 2005 | Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members | Limaye, V.; Li, X.; Hahn, C.; Xia, P.; Berndt, M.; Vadas, M.; Gamble, J. |
| 2008 | Tumor necrosis factor-like weak inducer of apoptosis attenuates the action of insulin in hepatocytes | Feng, F.; Wang, L.; Albanese, N.; Holmes, A.; Xia, P. |
| 1998 | Tumor necrosis factor-α induces adhesion molecule expression through the sphingosine kinase pathway | Xia, P.; Gamble, J.; Rye, K.A.; Wang, L.; Hii, C.; Cockerill, P.; Khew-Goodall, Y.; Bert, A.; Barter, P.; Vadas, M. |
